Medication info

Bonvanel Injection (Ibandronic Acid Sodium Hydrate)

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Ibandronate Sodium Monohydrate›3.375mg / 1 prefilled syringe
Manufacturer / importer
iWorld Pharmaceutical Co., Ltd.
Appearance
A colorless and transparent solution in a colorless and transparent glass prefilled syringe with a single-use syringe needle attached.
Packaging
3ml x 1 vial
Approval status
Active

MFDS item code 201900324 · Notified 2019.01.22 · Insurance code 669605231

Summary

Main use
Treatment of osteoporosis in postmenopausal women
Who receives it
Adults · Children
Adult administration
Administer 3mg by intravenous injection over 15 - 30 seconds once every 3 months. Patients should take calcium and vitamin D supplements. If a dose is missed on the scheduled dosing date, administer the injection as soon as possible, then continue regular dosing at 3-month intervals from that date. Patients with hepatic impairment No dose adjustment is required. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment with serum creatinine of 200 µmol/L(2.3mg/dL) or less or creatinine clearance of 30ml/min or more. Administration of this medicine is not recommended in patients with serum creatinine greater than 200 µmol/L(2.3mg/dL) or creatinine clearance less than 30ml/min because clinical experience is insufficient. Older adults No dose adjustment is required.
Child administration
Efficacy and safety have not been studied in children 18 years of age or younger.

Ingredients

Manufacturer
iWorld Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used to treat osteoporosis occurring in women after menopause. Women after menopause may have lower bone density due to decreased estrogen levels, which can result in an increased risk of fractures. This drug helps maintain bone health and improve bone density, thereby reducing the risk of fractures. Regular use can prevent the progression of osteoporosis and increase bone strength. Thus, it is effectively used for the management of postmenopausal osteoporosis.

How it is given

Adult administration

Administer 3mg by intravenous injection over 15 - 30 seconds once every 3 months. Patients should take calcium and vitamin D supplements. If a dose is missed on the scheduled dosing date, administer the injection as soon as possible, then continue regular dosing at 3-month intervals from that date. Patients with hepatic impairment No dose adjustment is required. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment with serum creatinine of 200 µmol/L(2.3mg/dL) or less or creatinine clearance of 30ml/min or more. Administration of this medicine is not recommended in patients with serum creatinine greater than 200 µmol/L(2.3mg/dL) or creatinine clearance less than 30ml/min because clinical experience is insufficient. Older adults No dose adjustment is required.

Child administration

Efficacy and safety have not been studied in children 18 years of age or younger.

Precautions

This medication must be administered solely as an intravenous injection, and extreme caution is required as injection into the artery or near the vein can cause tissue damage. It should not be used in patients with allergies to this drug or its components, or in untreated hypocalcemia patients. The use of this drug may cause gastrointestinal-related symptoms such as gastritis, diarrhea, abdominal pain, dyspepsia, nausea, and constipation, as well as symptoms like musculoskeletal pain, arthralgia, and myalgia. Additionally, symptoms similar to influenza such as fever, chills, fatigue, arthralgia, and myalgia may temporarily occur; these symptoms are usually mild and resolve naturally within a short period. Long-term use of this medication can rarely lead to serious side effects such as osteonecrosis of the jaw or bones around the ear, so it is important to thoroughly check oral health before dental treatment. Similar side effects reported include eye inflammation or severe allergic reactions, skin rashes, etc., and if such symptoms occur, immediate medical attention should be sought. This medication can temporarily lower serum calcium levels, so it is necessary to check for hypocalcemia or bone metabolic disorders before administration and ensure adequate intake of calcium and vitamin D. In patients with kidney issues or those on other medications, regular monitoring during treatment is required. The safety of this drug in pregnant or breastfeeding women has not been established, so it is advisable not to use it. In cases of overdose, careful monitoring is needed as it may affect kidney and liver function, and calcium, phosphate, or magnesium supplementation may be necessary. This drug should not be mixed with calcium-containing solutions or other intravenous medications, and used syringes and needles should not be reused but disposed of safely. Finally, the effects of this medication on driving or operating machinery are unknown, so caution is advised.

Side effects

  • Gastritis
  • diarrhea
  • abdominal pain
  • indigestion
  • nausea
  • constipation
  • musculoskeletal pain
  • arthralgia
  • myalgia
  • influenza-like illness
Show 65 more
  • fatigue
  • headache
  • rash
  • bone pain
  • weakness
  • injection site reaction
  • phlebitis
  • thrombophlebitis
  • hypersensitivity reaction
  • angioedema
  • facial swelling
  • edema
  • urticaria
  • uveitis
  • episkleritis
  • scleritis
  • anaphylactic reaction
  • shock
  • asthma exacerbation
  • Stevens-Johnson syndrome
  • erythema multiforme
  • vesicular dermatitis
  • atypical stress fractures
  • intramedullary femoral fractures
  • myalgia
  • arthralgia
  • indigestion
  • influenza-like illness
  • musculoskeletal pain
  • headache
  • gastritis
  • nausea
  • fatigue
  • dizziness
  • fever
  • hypothyroidism
  • peripheral neuropathy
  • hearing loss
  • dyspnea
  • skin exfoliation
  • multiple organ dysfunction
  • death
  • dizziness
  • fractures
  • optic nerve atrophy
  • lower motor neuron lesions
  • tremor
  • unspecified gastrointestinal disease
  • benign gastrointestinal neoplasm
  • toothache
  • hyperventilation
  • cough
  • laryngitis
  • vaginitis
  • menopausal symptoms
  • insomnia
  • anxiety
  • tinnitus
  • lipoma
  • conjunctival hemorrhage
  • heart failure
  • urinary disorders
  • hematuria
  • sensory loss
  • acute renal failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container at room temperature between 1 degrees and 30 degrees Celsius. Storing it this way helps maintain the drug's efficacy and prevents deterioration.

Appearance and packaging

Appearance

A colorless and transparent solution in a colorless and transparent glass prefilled syringe with a single-use syringe needle attached.

Package unit

3ml x 1 vial

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.